The FDA has revoked the authorization status of monoclonal antibody treatments , effectively shutting down the treatment option for patients exposed to COVID-19.
The FDA gave no advanced notice of their arbitrary decision; they just issued a press release Monday evening and immediately revoked the Emergency Use Authorization.
On the surface the FDA justification is essentially that monoclonal antibody treatments are "Unlikely to be active against the omicron variant," so the monoclonal treatment option is revoked.
Below the surface it looks like the FDA reason for the revocation is to push the Pfizer and Merck pills as the primarily authorized therapeutics.
Literally, a few hours before the FDA shut down monoclonal antibody treatments to push the pills, CBS writes an article about how difficult it is to find therapeutic pills.
If public health was really the driving factor, why wouldn't federal public health officials make every effort to have all treatments available, and then let your doctor decide which is right for you?
The state of Florida Health Department is not happy and being forced to close all monoclonal antibody treatment sites.
It's becoming increasingly difficult to discern fact from fiction, and unfortunately the media has a strong bias. They spin stories to make conservatives look bad and will go to great lengths to avoid reporting on the good that comes from conservative policies. There are a few shining lights in the media landscape-brave conservative outlets that report the truth and offer a different perspective. We must support conservative outlets like this one and ensure that our voices are heard.
Tuesday, January 25, 2022
Without Notice FDA Revokes Monoclonal Antibody Treatments for COVID, Promote Difficult to Find Pfizer and Merck Pills as Replacements
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment